Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Cristina Mussini et al.|Clinical Infectious Diseases|2021Cited by 264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)Marco Falcone, Donatella Palazzo, Giusy Tiseo et al.|Clinical Infectious Diseases|2023Cited by 156
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortagePasquale De Nardo, Davide Mangioni, Elisa Gentilotti et al.|International Journal of Infectious Diseases|2020Cited by 75
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)Ivan Gentile, Nicola Coppola, Riccardo Scotto et al.|Hepatology International|2018Cited by 63
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel OpinionIvan Gentile|Antibiotics|2022Cited by 35